# Service Corporation International (SCI) — Investment Thesis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-27  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/SCI/financials · /stocks/SCI/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/SCI/memo ($2.00, Bearer token).

## Business Model

---
source: coverage-next-full
ticker: SCI
company: Service Corporation International
step: 01
title: Business Overview & Value Chain
date: 2026-05-27
---

### Step 01 — Business Overview: Service Corporation International (SCI)

#### 1. Executive Summary

Service Corporation International (SCI) is the largest death care services company in North America, operating funeral homes, cemeteries, and cremation centers. Founded in 1962 by Robert Waltrip in Houston, Texas, SCI has grown from a single funeral home to a 1,489-location funeral network and 496-cemetery portfolio through disciplined, decades-long consolidation [S1]. The company's competitive position is grounded in three structural advantages: (1) its unmatched geographic scale under the Dignity Memorial brand, (2) a $17.0 billion preneed contract backlog providing exceptional future revenue visibility, and (3) irreplaceable real estate assets in the cemetery business [S2].

#### 2. Business Model

SCI operates a two-segment model:

**Segment 1: Funeral (~55.8% of 2025 revenue)**
- Provides full-service funeral and cremation arrangements, both at-need (immediate death) and preneed (pre-arranged)
- Revenue sources: funeral services, casket sales, flower sales, transportation, memorialization
- Key brands: Dignity Memorial (full-service), National Cremation Society, Neptune Society (cremation)
- Revenue per call (average): ~$5,500–$6,000 (traditional); ~$2,000–$3,000 (direct cremation)
- 2025 funeral revenue: ~$2,406M; gross margin: ~20.6%

**Segment 2: Cemetery (~44.2% of 2025 revenue)**
- Sells cemetery property (burial plots, niches, mausoleums) and provides interment services
- Also sells pre-need property rights (cemetery real estate sold well in advance)
- Higher margins than funeral due to real estate component
- 2025 cemetery revenue: ~$1,904M; gross margin: ~33.8%

#### 3. Value Chain Layer Map

```
[UPSTREAM]
  Merchandise procurement (caskets, urns, vaults, flowers)
  Insurance carrier partnerships (preneed insurance funding)
  Cemetery land acquisition and perpetual care
  Funeral home acquisitions

[OPERATIONS CORE]
  Funeral directors (licensed professionals — state regulated)
  Cremation technicians
  Cemetery managers and groundskeepers
  Preneed sales counselors (commissioned sales force)
  Trust fund management (state-mandated trusts for preneed funds)

[CUSTOMER DELIVERY]
  At-need funeral arrangements (48–72 hour urgency)
  Cremation processing
  Cemetery interments and memorialization
  Grief support services

[DOWNSTREAM / FOLLOW-ON]
  Preneed contract fulfillment (future revenue recognition)
  Trust fund investment returns
  Adjacent plot sales to family members of existing customers
  Preneed insurance claims (insurance-funded preneed)
```

#### 4. Revenue Model Detail

**At-Need Revenue**: Recognized at time of service delivery; driven by death volume × average revenue per call. Subject to quarterly volatility from flu seasons, COVID waves, etc.

**Preneed Revenue Recognition**: Complex multi-step:
1. Customer signs preneed contract and pays
2. Cash deposited into state-mandated trust or used to purchase insurance policy
3. Revenue recognized upon *delivery* of the service (at death), not at sale
4. Trust fund investment returns flow into revenue as earned
5. Cemetery property (real estate) is recognized at time of sale (distinct from services)

**Trust & Insurance Backlog**: $17.0B preneed backlog (2025) represents contracts sold but not yet delivered. This is locked-in future revenue that will be recognized at death. ~$8.2B sits in trust assets (2025).

#### 5. Operating Locations (March 2025)

| Category | Count | Geography |
|----------|-------|-----------|
| Funeral service locations | 1,489 | 42 states, 8 Canadian provinces, DC, PR |
| Cemeteries | 496 | 44 states, 8 Canadian provinces |
| Combination (funeral + cemetery) | ~80+ | Co-located |

#### 6. Preneed Sales Engine

SCI's preneed sales force is a key differentiator:
- ~3,500 preneed sales counselors (estimate)
- Both funeral preneed and cemetery preneed sold in advance
- 2025 preneed funeral production: $1,198M
- 2025 preneed cemetery production: $1,421M
- Total 2025 preneed production: ~$2,619M

Preneed sales lock in future volume, reduce at-need volume dependency, and create an annuity-like backlog.

#### 7. Key Brand Portfolio

| Brand | Positioning |
|-------|-------------|
| Dignity Memorial | Premium full-service funeral/cemetery (flagship) |
| National Cremation Society | Affordable cremation specialist |
| Neptune Society | Cremation with scattering at sea option |
| Funeraria del Angel | Hispanic communities |
| Dignity Planning | Online preneed planning platform |

#### 8. Strategic Positioning

SCI competes primarily on trust, brand recognition, and geographic convenience rather than price. Key strategic thrusts:

1. **Cremation monetization**: Growing cremation volume while maintaining revenue per call through ancillary products and preneed
2. **Preneed expansion**: Higher preneed penetration increases backlog and reduces at-need volatility
3. **Bolt-on M&A**: ~20–30 funeral homes and occasional cemeteries acquired annually
4. **Capital return**: ~$600M+ returned to shareholders annually (buybacks + dividends)
5. **Technology**: Online funeral planning tools, e-commerce for flowers/merchandise

#### 9. Source Index

| ID | Source |
|----|--------|
| S1 | SEC 10-K FY2025 (filing date 2026-02-12); SCI operations overview |
| S2 | Q4 2025 Earnings Press Release, Feb 11, 2026; revenue by segment |
| S3 | StockAnalysis.com SCI financials page (accessed 2026-05-27) |
| S4 | Industry analysis via Tavily web search (2026-05-27) |

## Recent Catalysts

---
source: coverage-next-full
ticker: SCI
company: Service Corporation International
step: 12
title: Catalysts & Bull/Bear Analysis
date: 2026-05-27
---

### Step 12 — Catalysts & Bull/Bear Analysis: SCI

*Note: Earnings transcript analysis was not performed on this research path (coverage-next-full). Bull/Bear debate is inferred from consensus notes, press releases, filings, and recent analyst coverage.*

#### 1. Current Market Debate

The market consensus on SCI is **"Strong Buy" with ~25% implied upside** (avg target $96.33 vs. $76.87 price). The debate centers on three dimensions:

1. **Volume recovery timeline**: Q1 2026's -6.6% funeral volume decline raised questions about whether COVID pull-forward normalization will persist through 2026 or whether the underlying business is deteriorating
2. **Cremation mix compression**: How quickly does revenue/call decline as cremation mix rises beyond 65%?
3. **Leverage and buyback sustainability**: At $5.2B net debt, can SCI continue $400–500M buybacks per year? What happens if interest rates spike?

#### 2. Near-Term Catalysts (12 Months)

| Catalyst | Type | Probability | Impact |
|---------|------|------------|--------|
| Funeral volume recovery in Q2–Q4 2026 | Positive | Medium (60%) | EPS toward upper range of $4.05–$4.35 guidance |
| Cemetery preneed acceleration continues (Q1 +10%) | Positive | Medium-High (70%) | Backlog grows; future revenue visibility improves |
| Accretive acquisition announcement | Positive | High (80%) | ~$50–200M bolt-on; buyback pacing note |
| EPS guidance raise in Q2/Q3 2026 | Positive | Low-Medium (35%) | Stock re-rating possible |
| California-type regulatory action in another state | Negative | Low-Medium (25%) | One-time charge $15–50M; sentiment hit |
| Leverage increase above 4.0x Net Debt/EBITDA | Negative | Low (20%) | Rating concern; buyback reduction |

#### 3. Medium-Term Catalysts (2–4 Years)

| Catalyst | Type | Potential Impact |
|---------|------|----------------|
| Baby boomer mortality acceleration (2028–2030) | Positive | +2–4% volume/year; could add $150–300M incremental revenue |
| Cremation memorialization products take-up | Positive | Offsets per-call revenue compression |
| Preneed backlog reaching $20B+ | Positive | Multi-year revenue visibility; valuation re-rate |
| Successful Dignity Planning digital platform | Positive | Lower CAC for preneed; higher preneed conversion |
| Acquisition of large regional cemetery chain | Positive | Transformative; adds cemetery land value |

#### 4. Analyst Debate — Key Fault Lines

*Reconstructed from consensus data and filings (no transcripts available)*

**Bull Side Arguments**:
- SCI is the "ultimate demographic play" — baby boomers dying is an investment thesis with near-certainty
- $17B preneed backlog provides unmatched revenue visibility (>4x annual revenue)
- Management has delivered 8–12% EPS growth long-term through pricing + buybacks
- Current stock at $77 is below 2022 buyback prices; management signaling value with repurchase activity
- Cemetery land is a real asset with inflationary value; long-term holders benefit from embedded appreciation

**Bear Side Arguments**:
- Revenue growth is essentially zero in real terms; EPS growth is buyback-dependent
- Leverage is rising (3.73x Net Debt/EBITDA, above management's comfort midpoint)
- Cremation commoditization is a structural headwind that will accelerate over the next decade
- At 20x trailing P/E, SCI is not cheap enough to own given the cremation risk and leverage
- California AG action signals broader regulatory risk; preneed marketing practices are aggressive

#### 5. Variant Perception

The market appears to have **correctly priced in** the cremation mix headwind and post-COVID volume normalization. The underappreciated variant is:

1. **Boomer wave timing**: Street models assume ~1% volume growth per year through 2027. The actual boomer mortality acceleration may arrive earlier (2027–2028 onset), providing upside surprise.

2. **Cemetery business quality**: The market undervalues SCI's cemetery segment. Cemetery land is non-replicable, margin-accretive, and benefits from both traditional burial AND cremation memorialization. As cremation rises, the cemetery business diversifies into cremation gardens, scatter gardens, and memorial walls — protecting its economic contribution.

3. **Preneed trust returns**: With higher interest rates, SCI's $8.2B trust portfolio generates higher returns, boosting recognized revenue. This benefit is partly overlooked in modeling.

#### 6. Short Interest & Contrarian View

- Short interest: Low (death care companies are not typical hedge fund short targets)
- No known activist investor campaigns
- No meaningful options market signal suggesting imminent catalyst

The lack of short interest confirms the market views this as a stable, low-volatility compounder — not a contested company.

---

#### Bull Case — 3 Bullets

- **Demographic tailwind materializes early**: Baby boomer mortality accelerates to 2027–2028 (earlier than consensus); funeral volume inflects positive at +2–3% per year while SCI's pricing power continues at +3%; combined revenue growth reaches 5–6% annually, driving EBITDA to $1.5B+ by 2028 and EPS to $5.50–$6.00. Stock re-rates to 22x forward P/E = $110–$130 range.

- **Preneed machine continues compounding**: Cemetery preneed sales production sustains +8–10% growth (Q1 2026 trend) as digital platform (Dignity Planning) reduces acquisition costs; backlog grows to $20B by 2027; management raises long-term EPS growth target to 10–14%; buybacks continue at $400–500M/yr reducing share count to ~130M by 2027.

- **Capital allocation excellence is re-rated**: Market recognizes SCI's free cash flow yield (~5.2%), disciplined M&A, and growing dividend as a "Berkshire of death care" compounder; P/FCF re-rates from 19x to 22x; combined with ~$4.50 FCF/share by 2027, stock reaches $99–$110.

---

#### Bear Case — 3 Bullets

- **Cremation commoditization accelerates faster than expected**: Direct cremation providers (Tulip, Final Goodbye) capture 25%+ of the market below SCI's price floor; SCI's funeral revenue/call declines 5–7% annually as cremation mix hits 70% by 2028; operating income stagnates near $950M; EPS growth limited to 3–4%; stock de-rates to 17x earnings = $68–$72.

- **Leverage trap if rates remain elevated or rise**: SCI refinances $1–2B of near-term maturities at 5.5–6.5% (vs. current ~5.0% portfolio rate); interest expense rises to $300–$330M; FCF compresses to $450–$500M; buyback pace cut to $200–$250M; EPS growth slows to 3–5%; multiple compresses; stock revisits $65–$70.

- **Regulatory and compliance headwinds mount**: Following California AG precedent, Florida, Texas, and New York AGs investigate preneed sales practices; total settlements/fines reach $75–$150M over 2026–2028; reputational damage reduces preneed sales conversion; management distraction from legal defense; stock de-rates 15–20% from announcement effect; floor ~$62–$68.

---

#### 7. Source Index

| ID | Source |
|----|--------|
| S1 | StockAnalysis.com forecast — consensus EPS, price targets, analyst rating |
| S2 | Q1 2026 earnings highlights — gurufocus.com (May 2026) |
| S3 | Q4 2025 Press Release — cemetery preneed +10% Q1 signal |
| S4 | Moat analysis (Step 10) and External Risk Overlay (Step 11) |
| S5 | Industry analysis — Tavily search (cremation rates, competitive dynamics) |

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/SCI/memo

## Navigation

- Overview: /stocks/SCI
- Financials: /stocks/SCI/financials
- Thesis (this page): /stocks/SCI/thesis
- Investment Memo: /stocks/SCI/memo
- Coverage universe: /stocks